학술논문

Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens
Document Type
article
Source
Cell. 183(3)
Subject
Microbiology
Medical Microbiology
Biomedical and Clinical Sciences
Biological Sciences
Cannabinoid Research
Brain Disorders
Infectious Diseases
Digestive Diseases
2.1 Biological and endogenous factors
2.2 Factors relating to the physical environment
Aetiology
Infection
Animals
Arachidonic Acids
Bacterial Adhesion
Bacterial Proteins
Bacterial Secretion Systems
Citrobacter rodentium
Colon
Endocannabinoids
Enterobacteriaceae
Enterobacteriaceae Infections
Female
Gastrointestinal Microbiome
Glycerides
HeLa Cells
Host-Pathogen Interactions
Humans
Male
Mice
Inbred C57BL
Mice
Knockout
Monoacylglycerol Lipases
Salmonella
Virulence
Hela Cells
2-AG
2-arachidonoyl glycerol
EHEC
QseC
Salmonella enterica
endocannabinoids
enterohemorrhagic E. coli
gut-brain axis
locus of enterocyte effacement
type three secretion system
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
Endocannabinoids are host-derived lipid hormones that fundamentally impact gastrointestinal (GI) biology. The use of cannabis and other exocannabinoids as anecdotal treatments for various GI disorders inspired the search for mechanisms by which these compounds mediate their effects, which led to the discovery of the mammalian endocannabinoid system. Dysregulated endocannabinoid signaling was linked to inflammation and the gut microbiota. However, the effects of endocannabinoids on host susceptibility to infection has not been explored. Here, we show that mice with elevated levels of the endocannabinoid 2-arachidonoyl glycerol (2-AG) are protected from enteric infection by Enterobacteriaceae pathogens. 2-AG directly modulates pathogen function by inhibiting virulence programs essential for successful infection. Furthermore, 2-AG antagonizes the bacterial receptor QseC, a histidine kinase encoded within the core Enterobacteriaceae genome that promotes the activation of pathogen-associated type three secretion systems. Taken together, our findings establish that endocannabinoids are directly sensed by bacteria and can modulate bacterial function.